A carregar...
Bortezomib Reduces Preexisting Antibodies to Recombinant Immunotoxins in Mice()
Recombinant immunotoxin (RIT) therapy is limited in patients by neutralizing antibody responses. Ninety percent of patients with normal immune systems make neutralizing antibodies after one cycle of RIT, preventing repeated dosing. Furthermore, some patients have preexisting antibodies from environm...
Na minha lista:
| Publicado no: | J Immunol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323725/ https://ncbi.nlm.nih.gov/pubmed/25560410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1402324 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|